These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 8622100)
1. The role of aminoglycosides in modern therapy. Beaucaire G J Chemother; 1995 Jun; 7 Suppl 2():111-23. PubMed ID: 8622100 [TBL] [Abstract][Full Text] [Related]
2. Once-daily versus multiple-daily dosing of aminoglycosides. Craig WA J Chemother; 1995 Jun; 7 Suppl 2():47-52. PubMed ID: 8622110 [TBL] [Abstract][Full Text] [Related]
3. Single daily dosing of aminoglycosides. Preston SL; Briceland LL Pharmacotherapy; 1995; 15(3):297-316. PubMed ID: 7667165 [TBL] [Abstract][Full Text] [Related]
5. [Aminoglycosides in pediatrics]. Schaad UB Schweiz Med Wochenschr Suppl; 1996; 76():34S-38S. PubMed ID: 8677417 [TBL] [Abstract][Full Text] [Related]
6. Aminoglycosides are useful for severe respiratory tract infections. Craig WA; Andes D Semin Respir Infect; 1997 Dec; 12(4):271-7. PubMed ID: 9436954 [TBL] [Abstract][Full Text] [Related]
7. Aminoglycosides in hemodialysis patients: is the current practice of post dialysis dosing appropriate? O'Shea S; Duffull S; Johnson DW Semin Dial; 2009; 22(3):225-30. PubMed ID: 19386073 [TBL] [Abstract][Full Text] [Related]
8. Aminoglycosides in the intensive care unit: an old drug in a dynamic environment. Miyagawa CI New Horiz; 1993 May; 1(2):172-80. PubMed ID: 7922400 [TBL] [Abstract][Full Text] [Related]
9. Extended dosage intervals for aminoglycosides. Rodman DP; Maxwell AJ; McKnight JT Am J Hosp Pharm; 1994 Aug; 51(16):2016-21. PubMed ID: 7977422 [TBL] [Abstract][Full Text] [Related]
12. In nosocomial pneumonia, optimizing antibiotics other than aminoglycosides is a more important determinant of successful clinical outcome, and a better means of avoiding resistance. Schentag JJ; Birmingham MC; Paladino JA; Carr JR; Hyatt JM; Forrest A; Zimmer GS; Adelman MH; Cumbo TJ Semin Respir Infect; 1997 Dec; 12(4):278-93. PubMed ID: 9436955 [TBL] [Abstract][Full Text] [Related]
13. Management of aminoglycosides in the intensive care unit. Radigan EA; Gilchrist NA; Miller MA J Intensive Care Med; 2010; 25(6):327-42. PubMed ID: 20837630 [TBL] [Abstract][Full Text] [Related]
14. Overview of the efficacy of isepamicin in the adult core clinical trial programme. Carbon C J Chemother; 1995 Jun; 7 Suppl 2():79-85. PubMed ID: 8622115 [TBL] [Abstract][Full Text] [Related]
16. Do we still need the aminoglycosides? Durante-Mangoni E; Grammatikos A; Utili R; Falagas ME Int J Antimicrob Agents; 2009 Mar; 33(3):201-5. PubMed ID: 18976888 [TBL] [Abstract][Full Text] [Related]
17. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study. Deal EN; Micek ST; Reichley RM; Ritchie DJ Clin Ther; 2009 Feb; 31(2):299-310. PubMed ID: 19302902 [TBL] [Abstract][Full Text] [Related]
18. Single versus combined antibiotic therapy for gram-negative infections. Klibanov OM; Raasch RH; Rublein JC Ann Pharmacother; 2004 Feb; 38(2):332-7. PubMed ID: 14742774 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of the efficacy and safety of isepamicin compared with amikacin in the treatment of nosocomial pneumonia and septicaemia. Beaucaire G J Chemother; 1995 Jun; 7 Suppl 2():165-73. PubMed ID: 8622107 [TBL] [Abstract][Full Text] [Related]
20. The evolution of aminoglycoside therapy: a single daily dose. Deamer RL; Dial LK Am Fam Physician; 1996 Apr; 53(5):1782-6. PubMed ID: 8623702 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]